4:02 PM ET
8-K
Executive Compensation
Gyre Therapeutics Executive Compensation
Gyre Therapeutics entered into new employment agreements with CEO Ying Luo, Ph.D., and CFO Thomas Eastling to continue their service. The agreements establish annual base salaries of $500,000 and $339,066 respectively, along with target bonuses and severance provisions including salary continuation and accelerated equity vesting upon certain termination events.